Glenmark Pharma drops price of COVID-19 drug Favipiravir to Rs 75/tablet In a regulatory filing, Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs…
IIIT Delhi develops AI model for drug repositioning in treatment of COVID-19 This means that instead of manually going through available drugs, checking its effectiveness against COVID-19, AI can speed…
The effect of repurposed drugs on COVID-19 patients explained… There is a need for aggregation and analysis of the vast data that will be generated from the use of repurposed drugs such as…
Scientific Race for New Medicines and Vaccines for COVID-19 There has been a large push to the development of a coronavirus vaccine and antiviral medicines. Having observed promising…
Drug Repurposing and its impact While using such repurposed drugs individually may ultimately not yield a significant clinical benefit, carefully combined…
Glenmark launches Favipiravir: Medics say ‘no magic bullet’ for COVID The drug can, however, help amid rising cases of COVID-19 As Glenmark Pharmaceuticals launched antiviral drug…
Artificial intelligence as COVID-19 drug discovery booster Dr D Narayana, Professor, AIML, D Arpna, S Peeyushi, S Samiksha, V Sanjay and P Sneha, Researchers, Great Learning discuss use of…